-transparent.png){kind=logo}
The availability of constantly more sophisticated algorithms and methods for dose planning (denoted 'level 3' procedures by the ICRU) makes it possible to use accordingly more complex treatment techniques. Such procedures have the potential of reducing irradiation of organs at risk and other healthy tissue. However, they suffer from a substantially more difficult set-up of the patient and verification of the treatment. This will introduce additional sources of error, systematic as well as random, which will be of importance for dose reporting. The purpose of this paper is to point out some of these problems and to suggest a method for reporting which is the least sensitive to these 'new' sources of error.
M Nilsson, and
T Landberg
February 1994,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
M Nilsson, and
T Landberg
October 1980,
Rinsho hoshasen. Clinical radiography,
M Nilsson, and
T Landberg
January 1996,
Frontiers of radiation therapy and oncology,
M Nilsson, and
T Landberg
February 1994,
International journal of radiation oncology, biology, physics,
M Nilsson, and
T Landberg
July 1994,
International journal of radiation oncology, biology, physics,
M Nilsson, and
T Landberg
March 1997,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
M Nilsson, and
T Landberg
January 1996,
Rays,
M Nilsson, and
T Landberg
September 1988,
Medical dosimetry : official journal of the American Association of Medical Dosimetrists,
M Nilsson, and
T Landberg
October 1992,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
M Nilsson, and
T Landberg
June 1998,
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al],
